AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Ultrasound vs. Nasofibroscopy for Evaluating Dysphagia After Extubation in the ICU

RecruitingNAAges 18 Years - anyAllHospital H+ Queretaro
💬

In plain words

What the trial is, and whether it could suit you

The goal of this observational study is to evaluate the diagnostic performance and concordance of bedside cervical ultrasonography compared to Fiberoptic Endoscopic Evaluation of Swallowing (FEES) for the early detection of post-extubation dysphagia in critically ill adult patients. The main questions it aims to answer are: * What is the degree of diagnostic concordance (Kappa index) between cervical ultrasonography and nasofibroscopy (FEES) for detecting dysphagia in the Intensive Care Unit (ICU)? * What are the sensitivity, specificity, and predictive values of ultrasonography as a non-invasive screening tool compared to the gold standard (FEES)? * Are there specific cut-off points for ultrasonographic parameters (such as hyoid bone displacement and laryngeal elevation) that accurately identify patients at risk of aspiration? Methodology and Comparison: Researchers will evaluate a co

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Critically ill patients admitted to the Intensive Care Unit (ICU). * Patients aged 18 years or older. * Patients who have required orotracheal intubation and mechanical ventilation for a period exceeding 48 hours. * Patients successfully liberated from mechanical ventilation (post-extubation phase). * Obtainment of signed Informed Consent from the patient or their legal representative. Exclusion Criteria: * Patients with a known prior history of oropharyngeal dysphagia, esophageal disorders, or structural abnormalities of the upper airway. * Patients with pre-existing neurological diseases that compromise the swallowing reflex (e.g., advanced Parkinson's disease, previous stroke with residual dysphagia, Amyotrophic Lateral Sclerosis). * Patients with a history of head and neck surgery or radiotherapy. * Patients with a Glasgow Coma Scale (GCS) score \< 13 at the time of evaluation. * Patients with hemodynamic instability or severe respiratory distress that precludes the diagnostic procedures. * Anatomical limitations that prevent the correct placement of the ultrasound transducer or the introduction of the nasofibroscope (e.g., severe facial trauma, nasal obstruction). * Medical contraindication for Fiberoptic Endoscopic Evaluation of Swallowing (FEES).
💊

What it tests

  • Bedside Cervical Ultrasonography
  • Fiberoptic Endoscopic Evaluation of Swallowing (FEES)
📍

Where

1 site
Hospital H+
Querétaro City, Mexico
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy